Huons accelerates Phase 2 clinical trials for new dry eye biologic in U.S.

Huons Co. Ltd., a holding company of Huons Global Co. Ltd., announced on the 6^th that it signed agreements with sample manufacturing companies and contract service organizations for clinical trials to accelerate the clinical trials of ‘HU024,’ a dry eye treatment using recombinant protein, in the U.S.

According to Huons, HU024, a new biologic which can replace the existing anti-inflammatory dr...